STRATA Skin Sciences, Inc. (SSKN)

Market Cap	10.55M
Revenue (ttm)	33.56M
Net Income (ttm)	-10.09M
Shares Out	4.17M
EPS (ttm)	-2.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,623
Open	2.530
Previous Close	2.522
Day's Range	2.530 - 2.530
52-Week Range	2.510 - 5.900
Beta	1.09
Analysts	Strong Buy
Price Target	6.00 (+137.15%)
Earnings Date	May 14, 2025

About SSKN

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the tr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 28, 2005
• Employees: 106
• Stock Exchange: NASDAQ
• Ticker Symbol: SSKN
• Website: https://www.strataskinsciences.com

Financial Performance

In 2024, STRATA Skin Sciences's revenue was $33.56 million, an increase of 0.61% compared to the previous year's $33.36 million. Losses were -$10.09 million, -6.87% less than in 2023.

Analyst Forecast

According to one analyst, the rating for SSKN stock is "Strong Buy" and the 12-month stock price forecast is $6.0.

Price Target

$6.0

(137.15% upside)

Analyst Consensus: Strong Buy